News | October 18, 2023
Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Subscribe To Our Newsletter & Stay Updated
